"Direct Service Costs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Costs which are directly identifiable with a particular service.
Descriptor ID |
D004180
|
MeSH Number(s) |
N03.219.151.400.325 N05.300.375.250
|
Concept/Terms |
Direct Service Costs- Direct Service Costs
- Service Costs, Direct
- Cost, Direct Service
- Direct Service Cost
- Service Cost, Direct
- Costs, Direct Service
|
Below are MeSH descriptors whose meaning is more general than "Direct Service Costs".
Below are MeSH descriptors whose meaning is more specific than "Direct Service Costs".
This graph shows the total number of publications written about "Direct Service Costs" by people in this website by year, and whether "Direct Service Costs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 1 | 2 |
2002 | 0 | 1 | 1 |
2004 | 0 | 2 | 2 |
2006 | 0 | 1 | 1 |
2010 | 2 | 0 | 2 |
2014 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Direct Service Costs" by people in Profiles.
-
?pac?rov? Z, Epstein D, Garc?a-Moch?n L, Aparicio VA, Borges-Cosic M, L?pez Del Amo MP, Mart?n-Mart?n JJ. Cost-effectiveness of a primary care-based exercise intervention in perimenopausal women. The FLAMENCO Project. Gac Sanit. 2019 Nov - Dec; 33(6):529-535.
-
Nielsen M, Qaseem A. Hematuria as a Marker of Occult Urinary Tract Cancer: Advice for High-Value Care From the American College of Physicians. Ann Intern Med. 2016 Apr 05; 164(7):488-97.
-
Lombardi N, Freedman K, Tucker B, Austin L, Eck B, Pepe M, Tjoumakaris F. Economic analysis of athletic team coverage by an orthopedic practice. Phys Sportsmed. 2015 Nov; 43(4):355-9.
-
Brown MM, Brown GC, Lieske HB, Lieske PA. Financial return-on-investment of ophthalmic interventions: a new paradigm. Curr Opin Ophthalmol. 2014 May; 25(3):171-6.
-
Amin A, Hussein M, Battleman D, Lin J, Stemkowski S, Merli GJ. Appropriate VTE prophylaxis is associated with lower direct medical costs. Hosp Pract (Minneap). 2010 Nov; 38(4):130-7.
-
Gupta OP, Shienbaum G, Patel AH, Fecarotta C, Kaiser RS, Regillo CD. A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact. Ophthalmology. 2010 Nov; 117(11):2134-40.
-
Elman LB, Stanley L, Gibbons P, McCluskey L. A cost comparison of hospice care in amyotrophic lateral sclerosis and lung cancer. Am J Hosp Palliat Care. 2006 Jun-Jul; 23(3):212-6.
-
Calhoun EA, McNaughton Collins M, Pontari MA, O'Leary M, Leiby BE, Landis RJ, Kusek JW, Litwin MS. The economic impact of chronic prostatitis. Arch Intern Med. 2004 Jun 14; 164(11):1231-6.
-
Isezuo SA, Onayemi O. Attitudes of patients towards voluntary human immunodeficiency virus counselling and testing in two Nigerian tertiary hospitals. West Afr J Med. 2004 Apr-Jun; 23(2):107-10.
-
Platt M, Sperling MR. A comparison of surgical and medical costs for refractory epilepsy. Epilepsia. 2002; 43 Suppl 4:25-31.